Cigna (NYSE:CI) Price Target Increased to $190.00 by Analysts at Raymond James

Cigna (NYSE:CI) had its price objective lifted by Raymond James from $185.00 to $190.00 in a research note released on Friday morning, BenzingaRatingsTable reports. The brokerage currently has an outperform rating on the health services provider’s stock.

Other equities analysts have also recently issued research reports about the stock. Morgan Stanley cut their price objective on shares of Cigna from $241.00 to $207.00 and set an overweight rating on the stock in a research report on Friday, July 12th. Zacks Investment Research cut shares of Cigna from a buy rating to a hold rating and set a $164.00 price objective on the stock. in a research report on Tuesday, June 11th. Citigroup cut their price objective on shares of Cigna from $228.00 to $203.00 and set a buy rating on the stock in a research report on Monday, June 3rd. Cantor Fitzgerald reissued a buy rating and set a $245.00 price objective on shares of Cigna in a research report on Sunday, April 21st. Finally, UBS Group began coverage on shares of Cigna in a research report on Tuesday, April 23rd. They set a buy rating and a $185.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have given a buy rating to the stock. The stock has an average rating of Buy and a consensus price target of $217.58.

CI traded down $2.98 during trading on Friday, reaching $164.58. 1,905,886 shares of the stock traded hands, compared to its average volume of 2,029,551. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.89. The stock has a market capitalization of $64.48 billion, a PE ratio of 11.57, a PEG ratio of 0.88 and a beta of 0.70. The company has a 50-day simple moving average of $166.14. Cigna has a 12 month low of $141.95 and a 12 month high of $226.60.

Cigna (NYSE:CI) last issued its quarterly earnings results on Thursday, August 1st. The health services provider reported $4.30 EPS for the quarter, beating the Zacks’ consensus estimate of $3.74 by $0.56. The business had revenue of $34.38 billion for the quarter, compared to analysts’ expectations of $33.27 billion. Cigna had a net margin of 4.11% and a return on equity of 14.23%. The business’s quarterly revenue was up 198.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.89 earnings per share. Equities research analysts anticipate that Cigna will post 16.59 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently bought and sold shares of CI. Lowe Wealth Advisors LLC acquired a new stake in shares of Cigna in the 1st quarter worth about $34,000. Truvestments Capital LLC acquired a new stake in shares of Cigna in the 1st quarter worth about $37,000. Lavaca Capital LLC acquired a new stake in shares of Cigna in the 1st quarter worth about $40,000. C J Advisory Inc acquired a new stake in shares of Cigna in the 1st quarter worth about $40,000. Finally, TRUE Private Wealth Advisors acquired a new stake in shares of Cigna in the 2nd quarter worth about $40,000. Institutional investors own 88.11% of the company’s stock.

About Cigna

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Featured Story: Exchange-Traded Funds (ETFs)

Analyst Recommendations for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.